AT
Alex Thompson Stifel Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
16
Avg Return
Past Year
Past Year
39%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
82.4%
Neutral
17.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $85 |
42%
upside
| 3 | +19% |
0
%
| 5 Mar ‘26 4 days ago |
|
|
|
Buy
Reiterated
| $68 |
121%
upside
| 1 | -0.29% |
0
%
| 26 Feb ‘26 11 days ago |
|
|
|
Buy
Initiated
| $44 |
64%
upside
| 1 | -4.4% |
0
%
| 25 Feb ‘26 12 days ago |
|
|
|
Buy
Initiated
| $5 |
187%
upside
| 1 | -2.8% |
0
%
| 25 Feb ‘26 12 days ago |
|
|
|
Buy
Maintained
| $256 |
7%
upside
| 2 | +12% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $1,248 |
69%
upside
| 1 | -17% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $65 |
18%
downside
| 1 | +109% |
0
%
| 12 Sep ‘25 5 months ago |
|
|
|
Hold
Maintained
| $25 |
14%
downside
| 2 | – |
–
| 12 Sep ‘25 5 months ago |
|
|
|
Buy
Reinstated
| $22 |
44%
upside
| 1 | +70% |
0
%
| 11 Jun ‘25 9 months ago |
|
|
|
Buy
Reinstated
| $55 |
35%
downside
| 1 | +182% |
0
%
| 20 May ‘25 9 months ago |
|
|
|
Hold
Downgraded
| $5 |
7%
downside
| 1 | – |
–
| 28 Mar ‘25 11 months ago |
|
|
|
Buy
Initiated
| $36 |
108%
upside
| 1 | +127% |
0
%
| 25 Mar ‘25 11 months ago |
|
|
|
Buy
Initiated
| $60 |
57%
upside
| 1 | +6.3% |
0
%
| 25 Mar ‘25 11 months ago |
|